MDK and glioma: These observations are in line with previous work by our group showing that MDK expression promoted resistance to anticancer agent-induced differentiated glioma cell death via this tyrosine kinase receptor rather than PTPRz or other receptors that have been proposed to mediate MDK actions in other contexts 10.